3 'targeted' cancer drugs raise risk of fatal side effects
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients. read more...
Source: e! Science News - Tuesday, 7 February
Related articles:
- Less than eight hours ago
- 4Vote! Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
LabSpaces - Today
- Less than a few days ago
- 4Vote! 'Copper pump's' potential benefit in cancer treatment
PhysOrg - Yesterday
- 9Vote! Drug kills cancer cells by restoring faulty tumor suppressor
- Less than a week ago
- 5Vote! Viral skin cancer treatment targets protein
Futurity.org - 4 days ago
- Older News
- 5Vote! Team uses genomics to identify a molecular-based treatment for a viral skin cancer
- 5Vote! Gene-modified stem cell transplant protects patients from toxic side effects of chemotherapy
- 1Vote! Young Adults Raise Skin Cancer Risk with Sunburns, Indoor Tanning
Yahoo Science News - Thursday, 10 May
- 3Vote! Droplet array sheds light on drug-resistant cancer stem cells
- 9Vote! Use of Antipsychotic Drugs Raises Alarm -- Boston Sunday Globe
Harvard World Health News - Friday, 4 May
- 5Vote! Presence of fetal cells in women lowers risk of breast cancer but raises risk of colon cancer
e! Science News - Friday, 4 May
- 3Vote! Identified 115 proteins that would allow designing new generation anti-cancer drugs
- 5Vote! Supplements and cancer prevention: A cautionary tale
- 3Vote! Rapid identification of superbugs and new drugs to combat them
- 2Vote! Checkpoint protein is key to cancer drugs
- 2Vote! Another Side to Statins
ScienceNews - Friday, 20 April
- 3Vote! Target set on cancer gene MCL1
- 3Vote! Fatal crashes spike on U.S. tax day
- 4Vote! Tax Day Linked to Increase in Fatal Car Crashes
- 4Vote! Nanobubbles-chemo mix targets cancer
- 3Vote! Bioengineers develop artificial chip for testing how drugs interact with ion channels
